Acute Back Pain Decision Tool

Acute Back Pain Decision Tool

by ATIF ELNIL

0 ratings
$14.99 Free
In-App Purchases

Price history


Rating summary

Details

  • Released
  • Updated
  • May 6, 2026
  • May 11, 2026

Features

Acute Back Pain Decision Tool screenshot #1 for iPhone
Acute Back Pain Decision Tool screenshot #2 for iPhone
Acute Back Pain Decision Tool screenshot #3 for iPhone
Acute Back Pain Decision Tool screenshot #4 for iPhone
Acute Back Pain Decision Tool screenshot #5 for iPhone
Acute Back Pain Decision Tool screenshot #6 for iPhone
Acute Back Pain Decision Tool screenshot #7 for iPhone
Acute Back Pain Decision Tool screenshot #8 for iPhone
Acute Back Pain Decision Tool screenshot #9 for iPhone
iphone
ipad
🖼️Get Icon
Icons↘︎

About

Acute Back Pain Decision Tool — evidence-based clinical decision support for acute back pain assessment and management. FREE TO TRY — no purchase needed: - Red Flags — NICE criteria, urgent imaging triggers, serious pathology indicators - Cauda Equina Syndrome — symptoms, emergency MRI, surgical referral FULL ACCESS — £14.99 one-time purchase: Unlocks all sections including: - Cord Compression — MSCC pathway, dexamethasone, neurosurgery - Classification — mechanical vs non-mechanical vs referred - Mechanical Back Pain — management, physiotherapy, analgesia ladder - Radiculopathy — nerve root, disc herniation, management - Serious Pathology — infection, malignancy, fracture - Imaging — when to scan, MRI vs CT, reporting priorities - Discharge — safety netting, return criteria, referral pathways - References — NICE, SIGN guidelines One-time purchase. No subscription. Works fully offline. For clinical decision support only. Always apply clinical judgement.
Show more

What's New in Acute Back Pain Decision Tool

1.0.1

May 11, 2026

Version 1.0.1: Red Flags and Cauda Equina now free. Full access to all back pain sections via one-time £14.99 in-app purchase. No subscription required.

More
1

In-App Purchases

$14.99

Back Pain Tool — Full Access

All acute back pain sections. Full access.

Developer apps